These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 472542)

  • 1. [Frequency of Tay-Sachs carriers in a sample of Ashkenazi Jews from Mexico City (author's transl)].
    Lisker R; Pérez-Briceño R
    Rev Invest Clin; 1979; 31(2):127-30. PubMed ID: 472542
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
    Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
    N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group.
    Myerowitz R
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3955-9. PubMed ID: 3375249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygote advantage in Tay-Sachs carriers?
    Spyropoulos B; Moens PB; Davidson J; Lowden JA
    Am J Hum Genet; 1981 May; 33(3):375-80. PubMed ID: 7246543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tay-Sachs disease among Moroccan Jews.
    Vecht J; Zeigler M; Segal M; Bach G
    Isr J Med Sci; 1983 Jan; 19(1):67-9. PubMed ID: 6832951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].
    Peleg L; Gazit E; Goldman B; Akstein E
    Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957
    [No Abstract]   [Full Text] [Related]  

  • 7. Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.
    Peleg L; Frisch A; Goldman B; Karpaty M; Narinsky R; Bronstein S; Frydman M
    Eur J Hum Genet; 1998; 6(2):185-6. PubMed ID: 9781065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of psychiatric patients who are carriers of tay-sachs disease. Possible role of psychotropic drugs.
    Zelnik N; Khazanov V; Sheinkman A; Karpati AM; Peleg L
    Neuropsychobiology; 2000; 41(3):127-31. PubMed ID: 10754426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pedigree discriminant analysis of two French Canadian Tay-Sachs families.
    Keats BJ; Elston RC; Andermann E
    Genet Epidemiol; 1987; 4(2):77-85. PubMed ID: 2953646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tay-Sachs disease and HEXA mutations among Moroccan Jews.
    Kaufman M; Grinshpun-Cohen J; Karpati M; Peleg L; Goldman B; Akstein E; Adam A; Navon R
    Hum Mutat; 1997; 10(4):295-300. PubMed ID: 9338583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.
    Petersen GM; Rotter JI; Cantor RM; Field LL; Greenwald S; Lim JS; Roy C; Schoenfeld V; Lowden JA; Kaback MM
    Am J Hum Genet; 1983 Nov; 35(6):1258-69. PubMed ID: 6650504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based genetic education: sources of information in a Tay Sachs disease screening program.
    Clark M; Palmer R; Kontras S
    Ohio State Med J; 1982 Mar; 78(3):218-20. PubMed ID: 7078924
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of Tay-Sachs disease.
    Risch N
    Adv Genet; 2001; 44():233-52. PubMed ID: 11596986
    [No Abstract]   [Full Text] [Related]  

  • 15. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
    Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
    Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tay-Sachs disease carrier screening: a 21-year experience.
    D'Souza G; McCann CL; Hedrick J; Fairley C; Nagel HL; Kushner JD; Kessel R
    Genet Test; 2000; 4(3):257-63. PubMed ID: 11142756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Tay-Sachs disease: a note of caution.
    Rosner F
    J Clin Ethics; 1991; 2(4):251-2. PubMed ID: 1804394
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic profile of the South African Ashkenazi Jewish population.
    Lane AB; Dunn DS; Jenkins T
    S Afr Med J; 1985 Dec; 68(13):935-9. PubMed ID: 4081927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay-Sachs disease: high gene frequency in a non-Jewish population.
    Kelly TE; Chase GA; Kaback MM; Kumor K; McKusick VA
    Am J Hum Genet; 1975 May; 27(3):287-91. PubMed ID: 803011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.